Ken Griffin’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,512
| Closed | -$57.2K | – | 6784 |
|
|
2025
Q1 | $57.2K | Buy |
+21,512
| New | +$57.2K | ﹤0.01% | 5324 |
|
|
2024
Q3 | – | Sell |
-4,343
| Closed | -$40.2K | – | 6538 |
|
|
2024
Q2 | $40.2K | Buy |
+4,343
| New | +$40.2K | ﹤0.01% | 5241 |
|
|
2023
Q4 | – | Sell |
-2,231
| Closed | -$28.4K | – | 6534 |
|
|
2023
Q3 | $28.4K | Buy |
2,231
+1,602
| +255% | +$20.4K | ﹤0.01% | 5233 |
|
|
2023
Q2 | $19K | Buy |
+629
| New | +$19K | ﹤0.01% | 5265 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6454 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6590 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6563 |
|
|
2022
Q2 | – | Sell |
-58
| Closed | -$145K | – | 6756 |
|
|
2022
Q1 | $145K | Sell |
58
-45
| -44% | -$113K | ﹤0.01% | 5469 |
|
|
2021
Q4 | $265K | Buy |
103
+63
| +158% | +$162K | ﹤0.01% | 5235 |
|
|
2021
Q3 | $183K | Buy |
+40
| New | +$183K | ﹤0.01% | 5484 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6966 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6716 |
|
|
2020
Q4 | – | Sell |
-23
| Closed | -$240K | – | 5496 |
|
|
2020
Q3 | $240K | Buy |
+23
| New | +$240K | ﹤0.01% | 3989 |
|
|
2020
Q2 | – | Sell |
-19
| Closed | -$86K | – | 5180 |
|
|
2020
Q1 | $86K | Buy |
19
+7
| +58% | +$31.7K | ﹤0.01% | 4404 |
|
|
2019
Q4 | $75K | Buy |
+12
| New | +$75K | ﹤0.01% | 4338 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5061 |
|
|
2019
Q1 | – | Sell |
-18
| Closed | -$101K | – | 4931 |
|
|
2018
Q4 | $101K | Buy |
+18
| New | +$101K | ﹤0.01% | 4000 |
|
|
2018
Q2 | – | Sell |
-28
| Closed | -$145K | – | 4505 |
|
|
2018
Q1 | $145K | Sell |
28
-5
| -15% | -$25.9K | ﹤0.01% | 3567 |
|
|
2017
Q4 | $170K | Buy |
+33
| New | +$170K | ﹤0.01% | 3429 |
|